We are live on ! Find out more
TRIL

Trillium Therapeutics Inc.
TRIL

Delisted

TRIL was delisted on the 16th of November, 2021.

Back to rankings

2 hedge funds and large institutions have $18K invested in Trillium Therapeutics Inc. in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 177 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 181 → 2 (-179)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 177

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $1.38B → $18K (-$1.38B)

Holders
2
Holders Change
-179
Holders Change %
-98.9%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
177
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$107M
2
NMC
NEA Management Company
Maryland
-$101M
3
ACA
Avoro Capital Advisors
New York
-$100M
4
EAM
Eventide Asset Management
Massachusetts
-$91.8M
5
MF
Magnetar Financial
Illinois
-$57.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
PMAM
51
Picton Mahoney Asset Management
Ontario, Canada
– -$5.27M -300,000 Closed
Bank of America
52
Bank of America
North Carolina
– -$5.04M -286,918 Closed
WSL
53
Western Standard LLC
California
– -$4.66M -265,355 Closed
Balyasny Asset Management
54
Balyasny Asset Management
Illinois
– -$3.95M -225,000 Closed
Charles Schwab
55
Charles Schwab
California
– -$3.74M -213,112 Closed
AAA
56
Affinity Asset Advisors
New York
– -$3.51M -200,000 Closed
GI
57
GAMCO Investors
Connecticut
– -$3.51M -199,911 Closed
BHMP
58
Bardin Hill Management Partners
New York
– -$3.43M -195,192 Closed
LPL Financial
59
LPL Financial
California
– -$3.36M -191,328 Closed
Jane Street
60
Jane Street
New York
– -$3.05M -173,761 Closed
Swiss National Bank
61
Swiss National Bank
Switzerland
– -$3.01M -172,190 Closed
MCM
62
Moore Capital Management
New York
– -$2.94M -167,700 Closed
Marshall Wace
63
Marshall Wace
United Kingdom
– -$2.81M -160,062 Closed
SMC
64
S. Muoio & Co
New York
– -$2.81M -160,000 Closed
OAMG
65
Odey Asset Management Group
United Kingdom
– -$2.71M -154,409 Closed
VIA
66
Vident Investment Advisory
Georgia
– -$2.64M -150,259 Closed
WP
67
Woodline Partners
California
– -$2.46M -139,907 Closed
FTCM
68
First Trust Capital Management
Illinois
– -$2.43M -138,187 Closed
RhumbLine Advisers
69
RhumbLine Advisers
Massachusetts
– -$2.33M -132,421 Closed
EPM
70
Equitec Proprietary Markets
Illinois
– -$2.22M -126,597 Closed
State of Wisconsin Investment Board
71
State of Wisconsin Investment Board
Wisconsin
– -$2.22M -126,500 Closed
AGC
72
Angelo Gordon & Co
New York
– -$2.19M -125,000 Closed
CL
73
CSS LLC
Illinois
– -$2.04M -116,154 Closed
Capstone Investment Advisors
74
Capstone Investment Advisors
New York
– -$2.03M -115,451 Closed
HF
75
HRT Financial
New York
– -$2M -113,999 Closed
1 2
3
4 5

TRIL Hedge Fund Activity: Q4 2021 in Review

2 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Trillium Therapeutics Inc. (TRIL) for Q4 2021, worth a combined $18K — down 100% from $1.38B a quarter earlier.

Sellers outnumbered buyers: 177 funds closed out of TRIL and 1 opened new positions — a net loss of 176 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $107M sold.

  • 2 institutional investors held Trillium Therapeutics Inc. (TRIL) as of Q4 2021, down from 181 in Q3 2021.
  • Funds reported $18K of Trillium Therapeutics Inc. stock for Q4 2021, down 100% quarter-over-quarter.
  • 1 fund opened new Trillium Therapeutics Inc. positions in Q4 2021 and 177 closed out, a net change of -176 holders.
  • The largest Trillium Therapeutics Inc. seller in Q4 2021 was BlackRock, an estimated $107M sold.

Based on aggregated 13F filings for Q4 2021.